About Marksans Pharma Ltd
Marksans Pharma engaged in the business of research, manufacture, marketing and selling pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers; one located in Goa and the other in Navi Mumbai, Maharashtra.
Founded
1992
CEO
Mark Saldanha
Employees
2,235
HQ
Mumbai, India
Finished Products
1Sales
₹3,348.22Cr2Export incentives
₹10.25Cr3Scrap Sales
₹7.44Cr4Other Operating Revenues
₹3.21CrRaw Materials
1Raw Material Consumed
₹1,546.76Cr2Purchases
₹254.16CrAbout Marksans Pharma Ltd
Marksans Pharma engaged in the business of research, manufacture, marketing and selling pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers; one located in Goa and the other in Navi Mumbai, Maharashtra.
Founded:1992
CEO:Mark Saldanha
Employees:2,235
HQ:Mumbai, India
Finished Products
1Sales
₹3,348.22Cr2Export incentives
₹10.25Cr3Scrap Sales
₹7.44Cr4Other Operating Revenues
₹3.21CrRaw Materials
1Raw Material Consumed
₹1,546.76Cr2Purchases
₹254.16CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹346
52W Low
₹155
Volume6.57M
Avg VolumeN/A
Beta1.00
Dividend Yield0.27%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
28.91x
Valuation
P/B Ratio
4.98x
Valuation
EPS
₹11.50
Valuation
Dividend Yield
0.27%
Valuation
ROE
13.82%
Profitability
ROCE
17.37%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
US & North America52.0%
Europe and UK34.4%
Australia and New Zealand10.3%
Rest of World3.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.11x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
10.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.